Analysis of the regulatory mechanisms of ATF4 expression by the PI3K-mTOR pathway in lung cancer cell lines

被引:0
|
作者
Takahashi, Mizuki [1 ,2 ]
Kato, Yu [3 ]
Okamoto, Yuka [1 ]
Sugimoto, Yoshikazu [3 ]
Tomida, Akihiro [1 ]
机构
[1] JFCR, Genome Res, Canc Chemother Ctr, Tokyo, Japan
[2] Keio Univ, Chemother, Fac Pharm, Keio, Japan
[3] Keio Univ, Div Chemother, Fac Pharm, Keio, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-2345
引用
收藏
页码:1254 / 1254
页数:1
相关论文
共 50 条
  • [1] Mechanisms of resistance to dual PI3K-mTOR inhibition in NSCLC cell lines
    Heavey, S.
    Dowling, P.
    Barr, M.
    Cuffe, S.
    Finn, S.
    O'Byrne, K. J.
    Gately, K. A.
    LUNG CANCER, 2015, 87 : S2 - S2
  • [2] Resistance Mechanisms to PI3K-mTOR Inhibition in NSCLC
    Moore, Gillian
    Heavey, Susan
    O'Byrne, Kenneth
    Finn, Stephen
    Cuffe, Sinead
    O'Neill, Michael
    Gately, Kathy
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1277 - S1278
  • [3] TGFβ regulates vimentin expression and ATF4 function in osteoblasts via PI3K/AKT/MTOR signaling
    Lian, N.
    Wang, W.
    Nyman, J.
    Li, L.
    Elefteriou, F.
    Yang, X.
    BONE, 2011, 48 : S66 - S66
  • [4] The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines
    Riquelme, Ismael
    Tapia, Oscar
    Espinoza, Jaime A.
    Leal, Pamela
    Buchegger, Kurt
    Sandoval, Alejandra
    Bizama, Carolina
    Carlos Araya, Juan
    Peek, Richard M.
    Carlos Roa, Juan
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (04) : 797 - 805
  • [5] In depth molecular characterization of novel PI3K-mTOR inhibitor resistant NSCLC cell lines
    Heavey, Susan
    Dowling, Paul
    Toomey, Sinead
    Carr, Aoife
    Hennessy, Bryan
    O'Neill, Michael
    Barr, Martin P.
    Finn, Stephen
    Cuffe, Sinead
    O'Byrne, Kenneth J.
    Gately, Kathy
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
  • [6] TARGETING THE PI3K-mTOR PATHWAY AND ELUCIDATING MECHANISMS OF RESISTANCE IN A NOVEL AND RELEVANT ANIMAL MODEL OF GLIOBLASTOMA
    Dey, Brittany
    Wassell, Michelle
    Perez, Jennifer
    Stanton, Ann-Catherine
    Mack, Stephen
    Pollack, Ian
    Agnihotri, Sameer
    NEURO-ONCOLOGY, 2018, 20 : 270 - 270
  • [7] Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting
    Qiang, Min
    Chen, Zhe
    Liu, Hongyang
    Dong, Junxue
    Gong, Kejian
    Zhang, Xinjun
    Huo, Peng
    Zhu, Jingjun
    Shao, Yifeng
    Ma, Jinazun
    Zhang, Bowei
    Liu, Wei
    Tang, Mingbo
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [8] Leptin induced GRP78 expression through the PI3K-mTOR pathway in neuronal cells
    Thon, Mina
    Hosoi, Toru
    Yoshii, Michiko
    Ozawa, Koichiro
    SCIENTIFIC REPORTS, 2014, 4
  • [9] NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer
    Karki, Rajendra
    Man, Si Ming
    Malireddi, R. K. Subbarao
    Kesavardhana, Sannula
    Zhu, Qifan
    Burton, Amanda R.
    Sharma, Bhesh Raj
    Qi, Xiaopeng
    Pelletier, Stephane
    Vogel, Peter
    Rosenstiel, Philip
    Kanneganti, Thirumala-Devi
    NATURE, 2016, 540 (7634) : 583 - +
  • [10] The PI3K-mTOR signaling network and tumor cell metabolism.
    Manning, Brendan D.
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 16 - 16